Reddy who is part of the promoter family is serving as the vice chairman and whole-time director.
Reddy’s appointment will come into effect from January 1, 2022. The tenure of his appointment will end on May 31, 2024.
Reddy will be replacing N Govindarajan who has tendered his resignation as the managing director and a director on the company’s board citing personal reasons.
Govindarajan’s last day with the company is December 31.
“Mr. Reddy has been a key member of Aurobindo leadership and has played a pivotal role in the Company’s growth journey since inception. A veteran of the pharma industry, he has expertise in manufacturing technology and has been actively involved in the overall affairs and the strategic decision making of the Company,” Aurobindo said in a regulatory filing.
Reddy said he will look forward to working with colleagues on the Board and the Company on the business opportunities to execute on and to enhance value for our shareholders, employees and communities.
“I thank Govind for his service at Aurobindo over the last 10 years and wish him the best for his future endeavors,” Reddy said.
He also added that given the current size, scale and strategic importance of the company, it has identified multiple leaders to drive various businesses and they will be given the responsibility to drive the growth and profitability.
Reddy holds a master’s degree in Science (Chemistry). He has been associated with the Company since its initial days, as a promoter. He has expertise in manufacturing technology and is responsible for the overall affairs of the company and has held the position of managing director of the company in the past.